High prevalence of HIV, human papilloma virus (HPV), inadequate screening and treatment services for precancerous lesions, late diagnosis, limited access to timely, standard treatment of cancer and palliative care are the main risk factors for high cervical cancer incidence and mortality. HPV vaccination and effective programs to screen and treat women for pre-cancerous lesions (primary and secondary prevention, respectively) offer the opportunity to eliminate cervical cancer as a public health problem.
This new program aims to reach women with effective secondary prevention services by leveraging existing platforms such as multiplex diagnostics and VIA screening programs to deploy innovative tools on the market that are not yet widely used in Malawi such as HPV tests for screening, and portable devices to treat pre-cancerous lesions.
CHAI is therefore seeking an experienced, highly motivated, flexible, and result oriented individual to support scale up of secondary prevention of cervical cancer through innovative screening and treatment approaches. The Associate will be based in Lilongwe, Malawi with up to 50-75% travel in-country, and will report to the Program Manager, SRMNH.